[1] Novel Drug Approvals for 2022, https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022
[2] Paul Nathan et al. "Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma" Lancet 2021; 398: 803-816.